About: This symposium is an opportunity for scientists from academia and industry to discuss the latest academic and pre-clinical research and how it could be applied in the pharma and biotech industry to develop new treatments.

Our CE, Jeroen Verheyen, will speak about “Shaping the future of interdisciplinary interactions” during a panel discussin chaired by Kristin-Anne Rutter (Cambridge University Health Partners). The other panalists include Michael Anstey (Cambridge Innovation Capital), Jamie Blundell (Institute for the Early Detection of Cancer, University of Cambridge), Victoria Higgins (GlaxoSmithKline), and  Andy Neely (University of Cambridge).